2004
DOI: 10.1051/ject/200436116
|View full text |Cite
|
Sign up to set email alerts
|

North American Neonatal Extracorporeal Membrane Oxygenation (ECMO) Devices: 2002 Survey Results

Abstract: In mid 2002, surveys of active extracorporeal membrane oxygenation (ECMO) centers in the United States and Canada were conducted via E-mail regarding neonatal equipment and personnel. Seventy-four out of 99 (75%) North American ECMO centers listed in the Extracorporeal Life Support Organization (ELSO) directory responded to the survey. Of the responding centers, 95% use roller pumps, and the remaining 5% use centrifugal pumps. Silicone membrane oxygenators were used by 97% of the respondents, while 3% used hol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(6 citation statements)
references
References 8 publications
0
5
0
Order By: Relevance
“…Numerous ECMO equipment surveys indicate that there has been little change in the basic ECMO circuit design during the last two decades in the United States (2,7,8). The backbone of this standard ECMO system is the silicone membrane oxygenator, roller pump, and venous line bladder.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Numerous ECMO equipment surveys indicate that there has been little change in the basic ECMO circuit design during the last two decades in the United States (2,7,8). The backbone of this standard ECMO system is the silicone membrane oxygenator, roller pump, and venous line bladder.…”
Section: Discussionmentioning
confidence: 99%
“…This configuration has remained largely the same today. A 2002 survey of ELSO centers by Lawson et al found that 97% use the Kolobow silicone membrane oxygenator that was first developed in 1972 (2,3).…”
mentioning
confidence: 99%
“…ELSO recommends the use of unfractionated heparin and targeting the ACT of 180–220 seconds [ 1 ]. The recommendation was made depending on limited evidence and expert opinions [ 9 , 10 ]. The appropriate targeted ACT remains unknown.…”
Section: Introductionmentioning
confidence: 99%
“…Since 2002 there has been a steady shift in the components used for extracorporeal membrane oxygenation (ECMO) support (1)(2)(3). Centrifugal blood pumps have gained widespread use in ECMO as a result of advances in oxygenator technology.…”
mentioning
confidence: 99%